Arctic Bioscience AS

kr 2.39As of Sun 8 Nov 2026, 12:00 UTC
OSL:ABSHealthcare
Country Norway
PE (Fwd) •••
TSR 6Y CAGR (34.75%)
Div yield —
ROE (22.86%)
Biotechnology
Beta (5Y) 1.20
PE TTM —
TSR TTM (30.52%)
Mkt cap kr 64.43M
ROIC (8.13%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 2.62
9.74%
(41.34%)
Hold 9|4|6|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.03
0.03
0.03
0.04
9.85%
13.08%
7.07%
20.52%
Revenuekr M
6.263
6.331
6.466
6.508
8.94%
7.10%
5.06%
1.39%
Peers (US$6.815M)
Cap (US$)
PE
40.58M
—
Capital
TTM
5Y
10Y
Leveragex
1.166
0.240
0.207
EBIT/Intx
0.494
0.086
0.094
Own earn%
(21.25)
63.00
77.51
Sh yield%
15.41
39.84
38.96
Owners
Insiders/Inst%
4.15
68.87
Short interest%
1.25
SBC / revenue%
3.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
17–21
$1 testx
—
Incr. ROIC%
4